GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » Debt-to-Revenue

Medinet Co (TSE:2370) Debt-to-Revenue : N/A (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medinet Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Medinet Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円0.8 Mil. Medinet Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円0.0 Mil. Medinet Co's annualized Revenue for the quarter that ended in Sep. 2024 was 円0.0 Mil.


Medinet Co Debt-to-Revenue Historical Data

The historical data trend for Medinet Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinet Co Debt-to-Revenue Chart

Medinet Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.01 0.01 - -

Medinet Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - N/A

Competitive Comparison of Medinet Co's Debt-to-Revenue

For the Biotechnology subindustry, Medinet Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinet Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medinet Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medinet Co's Debt-to-Revenue falls into.


;
;

Medinet Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Medinet Co's Debt-to-Revenue for the fiscal year that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.781 + 0) / 768.501
=0.00

Medinet Co's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Medinet Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medinet Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Medinet Co Business Description

Traded in Other Exchanges
N/A
Address
1-1 Heiwajima 6-chome, 9th Floor, TRC Center Building, Ota-ku, Yokohama, JPN, 143-0006
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.

Medinet Co Headlines

No Headlines